L3D24

(1.3)
L1T101 (17%): Health care (50%), Health (44%)

L1T100 (11%): Hospital (64%)

L1T97 (7%): Health system (100%)

L1T80 (7%)

L1T79 (6%): Medication (100%)

L1T99 (5%)
L2DCommonL1DSpecificExamples
L2D89

(1.4)
L1T331 (13%): Trade union (29%), Working time (25%), Overtime (23%)

L1T334 (10%): Occupational safety and health (59%), Telecommuting (41%)

L1T337 (5%): Labour economics (88%)

L1T333 (4%): Work–life balance (100%)

L1T338 (4%): Employment (100%)

L1T309 (4%): Sustainability (73%)

L1T93 (3%): Disability (100%)

L1T112 (3%): Training (100%)

L1T456 (3%): Artificial intelligence (100%)

L1T457 (3%): Automation (72%)
L1D255

(2.1)
L1T379 (8%): General Data Protection Regulation (33%), Privacy (25%), Personal data (17%)

L1T222 (7%): European Union (23%)

L1T334 (6%): Occupational safety and health (55%)

L1T319 (5%): Ethics (49%)

L1T456 (5%): Artificial intelligence (45%), Intelligence (36%)

L1T181 (5%): Rights (44%)

L1T434 (4%): Trust (social science) (50%)

L1T223 (4%): Policy (58%)

L1T460 (4%): Safety (52%), Risk (48%)

L1T331 (4%): Trade union (25%), Right to disconnect (21%)
  • UNI Europa response to the European Commission consultation on AI ethics guidelines (1970) (1970) [+]
  • Working anytime, anywhere: The effects on the world of work (2017) (2017) [+]
  • Report Digital - EU-Ukraine Civil Society Platform (2019) (2019) [+]
  • Big Data Analytics Need Standards to Thrive: What Standards Are and Why They Matter (2019) (2019) [+]
  • European industrial policy on artificial intelligence and robotics (2019) (2019) [+]
  • Shaping the new world of work – how unions should address Artificial Intelligence (AI) (2019) (2019) [+]
  • Shaping the new world of work – how unions should address Artificial Intelligence (AI) (2019) (2019) [+]
  • Shaping the new world of work – how unions should address Artificial Intelligence (AI) (2019) (2019) [+]
  • Human-centric artificial intelligence (2019) (2019) [+]
  • Human-centric artificial intelligence (2019) (2019) [+]
  • Human-centric artificial intelligence (2019) (2019) [+]
  • Towards European Anticipatory Governance for Artificial Intelligence (2020) (2020) [+]
  • EU Social Partners agreement on digitalisation (2020) (2020) [+]
  • European social partners framework agreement on digitalisation (2020) (2020) [+]
  • AMENDMENTS 1 - 127 - Draft opinion Framework of ethical aspects of artificial intelligence, robotics and related technologies (2020) (2020) [+]
  • White Paper on AI - A European approach to excellence and trust (2020) (2020) [+]
  • Artificial Intelligence - A European approach to excellence and trust (2020) (2020) [+]
  • An Artificial Intelligence Standards Roadmap: Making Australia’s Voice Heard (2020) (2020) [+]
  • REPORT with recommendations to the Commission on a framework of ethical aspects of artificial intelligence, robotics and related technologies (2020) (2020) [+]
  • OPINION with recommendations to the Commission on a framework of ethical aspects of artificial intelligence, robotics and related technologies (2020) (2020) [+]
  • Techlash continues to batter technology sector (2021) (2021) [+]
  • AMENDMENTS 1 - 164 - Draft opinion Shaping the digital future of Europe: removing barriers to the functioning of the digital single market and improving the use of AI for European consumers (2021) (2021) [+]
  • Artificial Intelligence in the Modern World: Sub-Saharan African Perspective (2021) (2021) [+]
  • AMENDMENTS 1 - 201 - Draft report Shaping the digital future of Europe: removing barriers to the functioning of the digital single market and improving the use of AI for European consumers (2021) (2021) [+]
  • OECD AI Policy Observatory (2021) (2021) [+]
  • AMENDMENTS 1 - 164 - Draft opinion Shaping the digital future of Europe: removing barriers to the functioning of the digital single market and improving the use of AI for European consumers (2021) (2021) [+]
  • Recommendation of the Council on Artificial Intelligence (2021) (2021) [+]
L1D256

(2.7)
L1T10 (25%): Central Provident Fund (9%), Singapore (8%), Progressive wage (6%), Heng Swee Keat (6%), Jurong (5%)

L1T449 (5%): Small and medium-sized enterprises (27%), Entrepreneurship (18%), Startup company (18%)

L1T113 (3%): Preschool (44%)

L1T310 (3%): Productivity (40%), Economic growth (33%), Gross domestic product (27%)

L1T331 (3%): Overtime (17%), Minimum wage (15%), Working time (13%), National Trades Union Congress (12%), Socioeconomic mobility in the United States (12%)

L1T180 (3%): Rehabilitation (penology) (21%), Prison (18%), Prosecutor (17%), High Court (Singapore) (14%)

L1T337 (3%): Labour economics (58%), Unemployment (42%)

L1T328 (3%): Income (34%)

L1T91 (2%): Single parent (32%), Child (19%)

L1T338 (2%): Retirement (57%), Employment (32%)
  • Sitting on 4 March 2014 (2014) (2014) [+]
  • Sitting on 5 April 2016 (2016) (2016) [+]
  • Sitting on 24 March 2016 (2016) (2016) [+]
  • Basic Policy on Economic and Fiscal Management and Reform 2017 (2017) (2017) [+]
  • Basic Policy on Economic and Fiscal Management and Reform 2018 (2018) (2018) [+]
  • SINGAPORE PUBLIC SECTOR OUTCOMES (2018) (2018) [+]
  • Sitting on 7 May 2018 (2018) (2018) [+]
  • Sitting on 15 May 2018 (2018) (2018) [+]
  • Sitting on 5 October 2020 (2020) (2020) [+]
L2D90

(1.3)
L1T0 (16%)

L1T10 (8%): Singapore (86%)

L1T449 (6%): Startup company (36%), Research and development (36%), Entrepreneurship (27%)

L1T100 (5%): Patient (46%), Hospital (45%)

L1T416 (4%): Nanotechnology (100%)

L1T101 (4%): Health care (90%)

L1T78 (4%): Radiation therapy (43%), Medical imaging (35%)

L1T292 (3%): Fuel cell (100%)

L1T252 (3%)
L1D257

(2.0)
L1T10 (10%): ASEAN (8%), Ministry of Education (Singapore) (8%), Parliament of Singapore (7%), Singapore (5%), Stony Brook University (4%)

L1T0 (6%): Public Service Loan Forgiveness (4%), Pollutant Standards Index (4%), Ministry of Agriculture, Forestry and Fisheries (Japan) (4%), Employment Ice Age (4%), Wyandanch, New York (4%)

L1T393 (4%): Gender neutrality (24%), Gender role (17%), Sexism (16%), Woman (15%), Gender equality (15%)

L1T292 (4%): Coal pollution mitigation (29%), Carbon capture and storage (20%), Biofuel (19%), Fuel (15%)

L1T309 (3%): Sustainable development (40%), Resource (24%)

L1T453 (3%): Cyberwarfare (19%), Cyber resilience (19%), National Initiative for Cybersecurity Education (18%), Incident management (14%), Cyber-security regulation (10%)

L1T404 (2%): Poverty (66%)

L1T90 (2%): Psychiatry (34%), Major depressive disorder (32%), Mental disorder (26%)

L1T293 (2%): Energy policy of the United States (41%)

L1T275 (2%): Recycling (27%), Waste (25%), Waste minimisation (24%), Zero waste (23%)

L1T30 (2%): Loan (27%), Home Mortgage Disclosure Act (22%), Debtor (21%), Foreclosure (18%)

L1T113 (2%): Preschool (34%), Kindergarten (20%)

L1T273 (2%): World energy resources (48%), Coal (36%)

L1T416 (2%): Nanoparticle (37%), Clean coal technology (25%), Nanotechnology (22%)

L1T277 (1%): Air pollution (63%), Black carbon (37%)

L1T180 (1%): Defence Science and Technology Agency (26%), Police (20%), Crime (20%), Predictive policing (19%), Rehabilitation (penology) (16%)

L1T283 (1%): Human impact on the environment (48%), Biodiversity (33%)

L1T271 (1%): Agriculture (100%)

L1T284 (1%): Pollution (75%)
  • Toolkit gender in EU-funded research. (2011) (2011) [+]
  • Gender in EU-funded research : toolkit. (2014) (2014) [+]
  • Land Lines, October 2015 (2015) (2015) [+]
  • Riding the digital wave : the impact of cyber capacity building on human development. (2015) (2015) [+]
  • Long Island (2018) (2018) [+]
  • 令和元年 6 月 21 日 (2019) (2019) [+]
  • House Hearing, 116th Congress — MEMBERS' DAY HEARING (2019) (2019) [+]
  • Sitting on 6 August 2019 (2019) (2019) [+]
  • Sitting on 24 August 2020 (2020) (2020) [+]
  • Sitting on 15 October 2020 (2020) (2020) [+]
L1D258

(1.9)
L1T449 (7%): Research and development (21%), Entrepreneurship (19%), Startup company (17%), Venture capital (17%)

L1T18 (5%): Iceland (14%), Nordic countries (11%), Norway (11%), Denmark (9%), Aarhus (8%)

L1T450 (5%): Competition (24%), Mergers and acquisitions (24%), Business model (19%), Market (economics) (18%)

L1T77 (4%): Diabetes (16%), Chronic condition (15%), Self-care (11%), Body mass index (8%), Asthma (8%)

L1T75 (4%): Gait analysis (7%), Simon Stevens (healthcare manager) (7%), Kidney disease (7%), Pre-clinical development (7%), Adipose tissue (6%)

L1T252 (4%): Patent (23%), Patent application (17%), Invention (15%)

L1T101 (4%): Health care (48%)

L1T94 (3%): Adherence (medicine) (36%), Health information technology (23%)

L1T98 (3%): Health informatics (38%), Health data (31%)

L1T79 (3%): Clinical trial (47%), Medication (35%)

L1T0 (3%): Shizuoka University (5%), New Zealand wine (5%), Dodd-Walls Centre (5%), Kuopio (5%), Fast track (FDA) (5%)

L1T99 (3%): Telehealth (38%), Health technology in the United States (22%)

L1T100 (3%): Patient (55%), Hospital (37%)
  • Frontier firms: four industry case studies (1970) (1970) [+]
  • Systems of Innovation Within Public and Private Organizations: Case Studies and Options for the EPA: Appendices (2003) (2003) [+]
  • House Hearing, 113th Congress — INNOVATION AS A CATALYST FOR NEW JOBS (2013) (2013) [+]
  • Productivity, innovation and competitiveness in small open economies (2015) (2015) [+]
  • Unlocking the potential of the Internet of Things (2015) (2015) [+]
  • From health care capital to innovation hub: Positioning Nashville as a leader in health IT (2016) (2016) [+]
  • Innovate UK funding competition winners 2015 (2016) (2016) [+]
  • Leveraging public procurement to grow the innovation economy: an independent review of the Small Business Research Initiative (SBRI) (2017) (2017) [+]
  • Strongholds and Qualities of the Nordic Health Tech Ecosystem (2018) (2018) [+]
  • Nordic Infrastructure of Test Facilities (2018) (2018) [+]
  • Innovate UK funding competition winners 2016 (2018) (2018) [+]
  • HEALTHCARE AI (2019) (2019) [+]
  • Innovate UK funding competition winners 2018 (2019) (2019) [+]
  • Medical device innovation (2019) (2019) [+]
  • 大学発ベンチャー チームビルディング事例集 (2020) (2020) [+]
  • Regulator approaches to facilitate, support and enable innovation (2020) (2020) [+]
  • Who Is Winning the AI Race: China, the EU, or the United States? — 2021 Update (2021) (2021) [+]
  • Who Is Winning the AI Race: China, the EU, or the United States? — 2021 Update (2021) (2021) [+]
L2D91

(2.1)
L1T97 (10%): Health system (27%), Health policy (23%), Population health (14%)

L1T100 (7%): Health professional (29%), Patient (24%), Hospital (22%)

L1T94 (5%): Healthcare industry (24%)

L1T10 (4%): United States–Korea Free Trade Agreement (11%), South Korea (10%), National Bureau of Asian Research (10%), Japan (10%), Abenomics (9%)

L1T99 (4%): Telehealth (29%), Health technology in the United States (22%), Telemedicine (20%), MHealth (17%)

L1T449 (4%): Entrepreneurship (20%), Venture capital (19%), Knowledge economy (11%), Angel investor (11%), Startup company (10%)

L1T87 (3%): Disease (54%), Preventive healthcare (42%)

L1T239 (3%): Health insurance (39%)

L1T310 (3%): Gross domestic product (37%), Economic growth (31%), Productivity (30%)

L1T410 (3%): Quality of life (28%), Population ageing (21%), Ageing (21%), Birth rate (15%)

L1T311 (3%): Tax (39%), Subsidy (27%)

L1T86 (3%): Public health (58%)
L1D259

(1.6)
L1T97 (10%): Health system (27%), Health policy (23%), Population health (14%)

L1T100 (7%): Health professional (29%), Patient (24%), Hospital (22%)

L1T94 (5%): Healthcare industry (24%)

L1T10 (4%): United States–Korea Free Trade Agreement (11%), South Korea (10%), National Bureau of Asian Research (10%), Japan (10%), Abenomics (9%)

L1T99 (4%): Telehealth (29%), Health technology in the United States (22%), Telemedicine (20%), MHealth (17%)

L1T449 (4%): Entrepreneurship (20%), Venture capital (19%), Knowledge economy (11%), Angel investor (11%), Startup company (10%)

L1T87 (3%): Disease (54%), Preventive healthcare (42%)

L1T239 (3%): Health insurance (39%)

L1T310 (3%): Gross domestic product (37%), Economic growth (31%), Productivity (30%)

L1T410 (3%): Quality of life (28%), Population ageing (21%), Ageing (21%), Birth rate (15%)

L1T311 (3%): Tax (39%), Subsidy (27%)

L1T86 (3%): Public health (58%)
  • The Development of eServices in an Enlarged EU: eGovernment and eHealth in Estonia (2007) (2007) [+]
  • Medical Innovation and Government Intervention (2009) (2009) [+]
  • S.Hrg. 111-1018 — INNOVATION IN AMERICA: OPPORTUNITIES AND OBSTACLES (2010) (2010) [+]
  • eHealth Strategy for Ireland (2013) (2013) [+]
  • Kyrgyz Republic : Review of Social Policy and Expenditures, Volume 2. Health and Education Expenditures (2013) (2013) [+]
  • Sustainable Health Systems - Visions, Strategies, Critical Uncertainties and Scenarios (2013) (2013) [+]
  • Assessment of Governance and Corruption in the Pharmaceutical Sector : Lessons Learned from Low and Middle Income Countries (2013) (2013) [+]
  • Funding Canadian Health Care in 2035: Strategic Foresight Scenarios (2016) (2016) [+]
  • Sitting on 4 April 2016 (2016) (2016) [+]
  • First Regional Conference on National Health Planning, Manila, Philippines, 2-9 November 1972 : final report (2016) (2016) [+]
  • HEALTH CARE 2.0, Part 1: How to Think About Market Forces in Health Care (2016) (2016) [+]
  • Exploring the role and opportunities for open government data and new technologies : opportunities in Maternal Health and Child Care (MHCC) & Micro, Small, and Medium Enterprises (MSMEs); : the case of the Philippines (2016) (2016) [+]
  • Rebalancing National Health Systems: Innovation and Sustainability (2017) (2017) [+]
  • CEDA - Improving service sector productivity: the economic imperative (2017) (2017) [+]
  • Spurring private investment in global health research and development (2017) (2017) [+]
  • Moving Beyond the “Milkman” Model in Medtech (2017) (2017) [+]
  • Shifting the dial: 5 year productivity review (2017) (2017) [+]
  • Nordic Health Tech – Core Qualities and Strongholds (2017) (2017) [+]
  • The Unique Challenges for Life Science Innovation in Asia - The National Bureau of Asian Research (NBR) (2018) (2018) [+]
  • Inclusive Structural Change: Case Studies on Innovations in Breeding Practices in Kenya and Anti-Retroviral Therapy Service Provision in Mozambique (2018) (2018) [+]
  • Innovative Asia: Innovation Policy and the Implications for Healthcare and the Life Sciences - The National Bureau of Asian Research (NBR) (2018) (2018) [+]
  • Exploring the Context for Innovation Policy in Japan and South Korea - The National Bureau of Asian Research (NBR) (2018) (2018) [+]
  • Improving Population Health in the Era of Superaging: Japan's Challenges and Opportunities - The National Bureau of Asian Research (NBR) (2018) (2018) [+]
  • Innovations for Universal Health Coverage: A South-South Collaboration to Transform Health Systems in Africa and India (2018) (2018) [+]
  • The silver economy : final report : annexes. (2018) (2018) [+]
  • Smart (dis)investment choices in healthcare (2018) (2018) [+]
  • Global Innovation Index 2019 (2019) (2019) [+]
  • Smart business models with IMPACT. How to connect industry and… (2019) (2019) [+]
  • Healthcare in Emerging Markets: Exploring the Protection Gaps | Research report (2019) (2019) [+]
  • Imagining the Alternative Worlds of 2030: Policy Implications for the Future of Global Health Procurement (2019) (2019) [+]
  • Global Innovation Index 2019 - Executive version (2019) (2019) [+]
  • Estonia: health system review (2019) (2019) [+]
  • COVID-19: Win the Fight, Win the Future (2020) (2020) [+]
  • Global Innovation Index 2019 (2020) (2020) [+]
  • The Untapped Potential of Ecosystems in Health Care (2021) (2021) [+]
L2D92

(1.8)
L1T440 (5%): Transparency (behavior) (40%)

L1T202 (5%): Open data (37%), Data sharing (32%)

L1T261 (4%): Analytics (38%), Big data (27%), Data science (27%)

L1T101 (3%): National Health Service (31%), Health (28%), Health care (21%)

L1T379 (3%): Privacy (18%), Consent (14%), Information Commissioner's Office (10%), Personally identifiable information (10%), Data Protection Act 1998 (10%)

L1T15 (3%): Department for Work and Pensions (14%), Scotland (14%), Bill English (10%), Brexit (8%), Commonwealth of Nations (8%)

L1T195 (2%): Retail (18%), Customer (12%), Marketing (10%), Pricing (10%), Local number portability (9%)

L1T16 (2%): United Kingdom (83%)

L1T459 (2%): Data (57%), Information (43%)

L1T371 (2%): Decision-making (78%)

L1T433 (2%): Culture (58%), Education (42%)

L1T389 (2%): Six Sigma (27%), Benchmarking (21%), Project management (20%)

L1T392 (2%): Best practice (100%)

L1T186 (2%): Iowa (33%), Missouri (30%)

L1T426 (2%): Community (100%)

L1T458 (1%): Innovation (97%)

L1T262 (1%): Internet (100%)

L1T390 (1%): Management (60%)

L1T376 (1%): Social media (99%)

L1T435 (1%): Modernization theory (31%), Public policy (23%), Public administration (20%)

L1T223 (1%): Governance (57%), Policy (43%)

L1T201 (1%): Business process (59%)
L1D260

(1.5)
L1T440 (5%): Transparency (behavior) (40%)

L1T202 (5%): Open data (37%), Data sharing (32%)

L1T261 (4%): Analytics (38%), Big data (27%), Data science (27%)

L1T101 (3%): National Health Service (31%), Health (28%), Health care (21%)

L1T379 (3%): Privacy (18%), Consent (14%), Information Commissioner's Office (10%), Personally identifiable information (10%), Data Protection Act 1998 (10%)

L1T15 (3%): Department for Work and Pensions (14%), Scotland (14%), Bill English (10%), Brexit (8%), Commonwealth of Nations (8%)

L1T195 (2%): Retail (18%), Customer (12%), Marketing (10%), Pricing (10%), Local number portability (9%)

L1T16 (2%): United Kingdom (83%)

L1T459 (2%): Data (57%), Information (43%)

L1T371 (2%): Decision-making (78%)

L1T433 (2%): Culture (58%), Education (42%)

L1T389 (2%): Six Sigma (27%), Benchmarking (21%), Project management (20%)

L1T392 (2%): Best practice (100%)

L1T186 (2%): Iowa (33%), Missouri (30%)

L1T426 (2%): Community (100%)

L1T458 (1%): Innovation (97%)

L1T262 (1%): Internet (100%)

L1T390 (1%): Management (60%)

L1T376 (1%): Social media (99%)

L1T435 (1%): Modernization theory (31%), Public policy (23%), Public administration (20%)

L1T223 (1%): Governance (57%), Policy (43%)

L1T201 (1%): Business process (59%)
  • Modern Policy-Making: Ensuring Policies Deliver Value for Money (NAO) Report (2001) (2001) [+]
  • INITIATE - how we are implementing innovate - inspire - influence : the Health Products and Food Branch strategic plan 2016-2021. (2002) (2002) [+]
  • Making open data real (2011) (2011) [+]
  • The data dividend (2012) (2012) [+]
  • Enabling tomorrow’s public services (2012) (2012) [+]
  • Open data: Unlocking innovation and performance with liquid information (2013) (2013) [+]
  • Emerging technologies: big data (2014) (2014) [+]
  • Public Sector Data Management Report (2015) (2015) [+]
  • Debates (Hansard) No. 217 - May 26, 2015 (41-2) (2015) (2015) [+]
  • Building digital trust: the role of data ethics in the digital age (2016) (2016) [+]
  • Optimizing Government: A White Paper on Public Sector Modernization (2016) (2016) [+]
  • UK-France Data Innovation Taskforce Report (2016) (2016) [+]
  • The Best States for Data Innovation (2017) (2017) [+]
  • Open Government National Action Plan 2016 to 2018: mid-term self assessment (2017) (2017) [+]
  • The Best States for Data Innovation (2017) (2017) [+]
  • Powered by Blockchain, AI Potential Realized (2018) (2018) [+]
  • Digital Economy Act, part 5: data sharing codes and regulations (2018) (2018) [+]
  • Strengthening Communities with Neighborhood Data (2018) (2018) [+]
  • S = Philadelphia (2018) (2018) [+]
  • Commitments (2019) (2019) [+]
  • MITRE Response to the Commerce RFI: Leveraging Data as a Strategic Asset (CAP Goal #2) (2019) (2019) [+]
  • Fact-based policy: How do state and local governments accomplish it? (2019) (2019) [+]
  • Data Delivery Group meeting: October 2019 (2019) (2019) [+]
  • ESRI Research Strategy 2019-2023 (2019) (2019) [+]
  • The new ecosystem of trust (2019) (2019) [+]
  • Developing Artificial Intelligence Sustainably : Toward a Practical Code of Conduct for Disruptive Technologies (2020) (2020) [+]
  • PEG0185 - Post-pandemic economic growth (2020) (2020) [+]
  • Is the UK Getting Innovation Right? (2020) (2020) [+]
  • Is the UK getting innovation right? (2020) (2020) [+]
  • Evaluation of the Regulators’ Pioneers Fund (RPF) - Round 1 (2021) (2021) [+]
  • Valto: COVID-19-tutkimuskatsaus 5/2021 (2021) (2021) [+]
  • Valto: COVID-19-tutkimuskatsaus 9/2021 (2021) (2021) [+]
L2D93

(2.1)
L1T80 (17%): Pharmaceutical industry (26%), Medical research (25%), Drug development (16%), Biobank (16%)

L1T101 (9%): Health care (38%), National Health Service (32%), Health (19%)

L1T79 (7%): Medication (48%), Clinical trial (43%)

L1T81 (7%): Medicine (44%), Health sciences (26%)

L1T419 (5%): Biotechnology (40%), Biopharmaceutical (38%)

L1T84 (5%): Antimicrobial resistance (22%), Infection (21%), Antibiotic (18%), Epidemic (14%), Pandemic (12%)

L1T417 (4%): Drug discovery (38%), Whole genome sequencing (34%), Genetics (29%)
L1D261

(1.8)
L1T84 (5%): Epidemic (14%), Antibiotic (12%), Pandemic (12%), Infection (11%), Antimicrobial resistance (9%)

L1T80 (4%): Pharmaceutical industry (23%)

L1T83 (4%): Tuberculosis (22%), Global health (18%), Disease burden (16%), Global Health Initiatives (13%)

L1T448 (4%): Economy (58%), Investment (42%)

L1T14 (3%): Charitable organization (18%), The Midlands (13%), Leeds City Region (12%), New York (state) (11%), Greater Manchester (9%)

L1T419 (3%): Biotechnology (53%), Biopharmaceutical (32%)

L1T310 (3%): Economic growth (32%), Productivity (31%), Gross domestic product (24%)

L1T86 (3%): Public health (37%), Disability-adjusted life year (33%)

L1T79 (2%): Medication (54%), Clinical trial (36%)

L1T87 (2%): Disease (54%), Preventive healthcare (46%)

L1T81 (2%): Medical diagnosis (27%), Surgery (23%), Alternative medicine (22%), Medicine (21%)

L1T450 (2%): Market (economics) (49%)

L1T449 (2%): Funding (27%), Research and development (26%), Startup company (20%)

L1T199 (2%): Infrastructure (70%)

L1T101 (2%): Health care (46%)

L1T0 (2%): Risk–return spectrum (8%), Self-organized criticality (8%), The Human Use of Human Beings (8%), Genotype–phenotype distinction (8%), UCB (company) (8%)

L1T311 (2%): Economic development (34%), Tax (30%), School voucher (22%)

L1T77 (2%): Chronic condition (32%), Institute for Health Metrics and Evaluation (21%)

L1T336 (2%): Manufacturing (45%), Industry (34%)
  • The Role if Information technology in Designs of Healthcare Trade (1970) (1970) [+]
  • Dispositivos médicos: la gestión de la discordancia: un resultado del proyecto sobre dispositivos médicos prioritarios (2012) (2012) [+]
  • The University of Rochester Economic Impact (2014) (2014) [+]
  • Open for business: How open data can help achieve the G20 growth target (2014) (2014) [+]
  • Nesta Ideas Bank: ideas to transform Scotland (2016) (2016) [+]
  • Information and Communications Technologies and the New Globalization (2017) (2017) [+]
  • Private Sector Investment in Global Health R&D (2017) (2017) [+]
  • U.S.-China Links in Health and Medical Products: Risks and Opportunities - The National Bureau of Asian Research (NBR) (2019) (2019) [+]
  • Biopharmaceuticals : priority sector report. (2019) (2019) [+]
  • The new government's in tray (2019) (2019) [+]
  • A technical report for the research on (2019) (2019) [+]
  • The price of the status quo (2020) (2020) [+]
  • The science-based economy: The role of health research (2020) (2020) [+]
  • Horizon 2020, NNOSUP-1 cluster facilitated projects for new industrial value chains : impact report : June 2020. (2020) (2020) [+]
  • 15 December 2020 (2020) (2020) [+]
L1D262

(2.1)
L1T80 (20%): Medical research (13%)

L1T101 (10%): National Health Service (28%), Health care (24%), Health (18%), Medical device (16%)

L1T79 (7%): Clinical trial (43%), Medication (43%)

L1T81 (7%): Medicine (45%), Health sciences (39%)

L1T417 (5%): Biology (18%), Life sciences (15%), Genomics (15%)
  • Powerful partnerships. (2002) (2002) [+]
  • Scientific Infrastructure - Evidence (2013) (2013) [+]
  • Developing a connected health economy (2015) (2015) [+]
  • Accelerated access pathways for medical technologies (2016) (2016) [+]
  • Leaving the EU: implications and opportunities for science and research (2016) (2016) [+]
  • Healthier lives, stronger economy: Victoria's health and medical research strategy 2016-2020 (2016) (2016) [+]
  • What can research do to improve productivity in the NHS? (2016) (2016) [+]
  • Greater Manchester And Cheshire East (2016) (2016) [+]
  • Australian Medical Research and Innovation Strategy 2016–2021 (2016) (2016) [+]
  • China's Pursuit of Next Frontier Tech: Computing, Robotics, and Biotechnology - The National Bureau of Asian Research (NBR) (2017) (2017) [+]
  • April 2017 (2017) (2017) [+]
  • September 2017 (2017) (2017) [+]
  • January 2017 (2017) (2017) [+]
  • Bioscience and health technology database: annual report 2016 (2017) (2017) [+]
  • The interim evaluation of the Innovative Medicines Initiative 2 Joint Undertaking (2014-2016) operating under Horizon 2020 : experts group report. (2017) (2017) [+]
  • Ex-post evaluation of the health theme in FP7 : case studies executive summary. (2017) (2017) [+]
  • Life sciences: Sector Deal (2017) (2017) [+]
  • Life sciences: Sector Deal (2017) (2017) [+]
  • Personalised medicine : current status. (2017) (2017) [+]
  • Accelerating the translation of early detection and diagnosis research in cancer (2018) (2018) [+]
  • Bioscience and health technology database: annual report 2017 (2018) (2018) [+]
  • Department of Health and Social Care Department for Business, Energy and Industrial Strategy (2018) (2018) [+]
  • Life Sciences Industrial Strategy: Who’s driving the bus? evidence (2018) (2018) [+]
  • Rapporto sulla rilevazione delle apparecchiature sanitarie in Italia (2018) (2018) [+]
  • Picture (2018) (2018) [+]
  • Keeping up with the science: Innovation in the health and care system post Brexit (2018) (2018) [+]
  • Royaume-Uni (2018) (2018) [+]
  • MHRA Corporate Plan 2018 to 2023 (2018) (2018) [+]
  • Supporting clinical trials and the UK’s future clinical research capability (2019) (2019) [+]
  • Existing indicators to measure the biomedical innovation ecosystem (2019) (2019) [+]
  • C190102 - UK Science, Research and Technology Capability and Influence in Global Disease Outbreaks (2020) (2020) [+]
  • DEL0119 - Delivering Core NHS and Care Services during the Pandemic and Beyond (2020) (2020) [+]
  • DGT0022 - Digital Transformation in the NHS (2020) (2020) [+]
  • WHO, WIPO, WTO Joint Technical Symposium on Cutting-Edge Health Technologies: Opportunities and Challenges (2020) (2020) [+]
  • Life sciences industrial strategy update (2020) (2020) [+]
  • Reformer Thoughts: 'The future of post-Brexit regulation' (2020) (2020) [+]
  • Clinical academia for the future: research leaders and innovators (2020) (2020) [+]
  • INS0054 - Post-pandemic economic growth: Industrial Strategy (2020) (2020) [+]
  • Reformer Thoughts: 'The future of post-Brexit regulation' (2020) (2020) [+]
  • Digitally Transforming the Patient Journey in Africa and Europe (2021) (2021) [+]
  • How EU policies can improve healthcare across Europe (2021) (2021) [+]
  • Focus on Sectors 2020 (2021) (2021) [+]
  • Academy of Medical Sciences ’ response to the open consultation on the MHRA ’ s Proposed Patient and (2021) (2021) [+]
L2D94

(1.6)
L1T64 (20%): Diagnosis (100%)

L1T75 (8%): Prostate cancer (54%), Chemotherapy (46%)

L1T100 (7%): Hospital (65%), Physician (35%)

L1T81 (7%): Medicine (69%)

L1T101 (6%): Health (62%), Health care (32%)

L1T366 (6%): Knowledge (100%)
L1D263

(3.0)
L1T64 (35%): Healthcare in the Netherlands (16%), Biomedical sciences (14%), Diagnosis (11%), Digital data (10%), Netherlands (10%)

L1T100 (6%): Hospital (46%), Physician (23%)

L1T366 (5%): Consciousness (50%), Knowledge (37%)

L1T459 (5%): Data (63%), Information (37%)
  • Eenheid van Taal in de Nederlandse zorg : Van eenduidige informatie-uitwisseling tot hulpmiddel voor betere zorg (1970) (1970) [+]
  • Informatisering in de gezondheidszorg; een toekomstverkenning (2004) (2004) [+]
  • Robotprostaatchirurgie: Vanzelfsprekend? (2011) (2011) [+]
  • Innoveren voor Gezondheid (2013) (2013) [+]
  • De meetbare mens (2016) (2016) [+]
  • De introductie van dure technologie in de zorg: analysekader en case studies (2017) (2017) [+]
  • Robotisering en automatisering op de werkvloer (2018) (2018) [+]
  • Digitale dokters. Een ethische verkenning van medische expertsystemen (2018) (2018) [+]
  • The approved doctor's manual (2018) (2018) [+]
  • Onderzoek: Horizonscan Medische Hulpmiddelen - haalbaarheidsstudie (2019) (2019) [+]
  • Digitale beslissingsondersteuning in de zorg : Een verkenning (2019) (2019) [+]
  • Foresight und Technikfolgenabschätzung: Monitoring von Zukunftsthemen für das Österreichische Parlament Berichtsversion: Juni 2019. Bericht-Nr. ITA-AIT-8; Institut für Technikfolgen-Abschätzung/Austrian Institute of Technology: Wien; im Auftrag von: Parlamentsdirektion. (2019) (2019) [+]
  • Gezondheid centraal (2019) (2019) [+]
  • Kamerbrief over visie op medische technologie (2019) (2019) [+]
  • De MedTech-markt: ontwikkelingen en impact op de zorg (2019) (2019) [+]
  • Resultaten onderzoek databeschikbaarheid voor artificiële intelligentie (AI) in de zorg (2020) (2020) [+]
  • Sociale en technologische innovatie (2020) (2020) [+]
  • Houtskoolschets acute zorg (2020) (2020) [+]
  • Sociale en technologische innovatie (2020) (2020) [+]
  • Patiëntveiligheid bij ICT-uitval in ziekenhuizen (2020) (2020) [+]
  • Gezondheidsapps en wearables. De ethiek van e-health deel 1 (2020) (2020) [+]
  • Onderzoek en advies e‐healthmonitor 2.0 (2020) (2020) [+]
  • Verslag wetenschappelijke discussiebijeenkomst COVID-19: Apps als onderdeel van een exitstrategie (2020) (2020) [+]
  • Zorginstituut Magazine april 2021 (2021) (2021) [+]
L1D264

(2.3)
L1T83 (6%): HIV/AIDS (19%)

L1T84 (5%): Vaccination (12%), Infection (10%), Vaccine (8%), Vector (epidemiology) (8%), Herd immunity (7%)

L1T85 (4%): Mortality rate (28%), Breastfeeding (25%), Diarrhea (17%), Pan American Health Organization (17%)

L1T86 (4%): World Health Organization (55%)

L1T400 (4%): Togo (11%), Guinea (10%), Africa (10%), Mali (10%), Senegal (10%)

L1T403 (4%): Non-governmental organization (48%)

L1T97 (3%): Health system (38%), Primary health care (23%), Health promotion (20%)

L1T408 (3%): United Nations (54%), UNICEF (31%)

L1T399 (3%): World Bank (42%), Developing country (24%)

L1T87 (3%): Disease (82%)

L1T429 (3%): Budget (60%)

L1T91 (3%): Child (33%), Family (32%), Adolescence (23%)

L1T101 (2%): Health (60%)

L1T17 (2%): Director general (27%), Ministry of Health (Italy) (25%), Rate (mathematics) (15%), Spending Review (14%)

L1T404 (2%): Poverty (46%)

L1T269 (2%): Veterinary medicine (22%), Nutrition (18%), M. S. Swaminathan (15%), Activity-based costing (13%), Dieting (12%)
  • IDRC annual report 2005-2006 (2009) (2009) [+]
  • Aplicación Del Articulador Semiajustable En La Rehabilitación Oclusal Por Prótesis Parcial Fija Sobre Dientes Naturales E Implantes. (2010) (2010) [+]
  • Implementing the new recommendations on the clinical management of diarrhoea : guidelines for policy makers and programme managers (2012) (2012) [+]
  • Servicios sanitarios locales : tercer informe del Comité de Expertos en Administraci'on Sanitaria [‎se reunió en Ginebra del 12 al 17 de octubre de 1959]‎ (2012) (2012) [+]
  • A Cost Analysis of the Honduras Community-based Integrated Child Care Program (2013) (2013) [+]
  • Relazione sullo Stato Sanitario del Paese (2014) (2014) [+]
  • D' Alma-Ata à l' an 2000: réflexions à la mi-parcours (2014) (2014) [+]
  • 46a Asamblea Mundial de la Salud, Ginebra, 3-14 de mayo de 1993: actas resumidas de las comisiones (2015) (2015) [+]
  • Consejo Ejecutivo, 93a reunión, Ginebra, 17-26 de enero de 1994: actas resumidas (2015) (2015) [+]
  • Statement / submitted by Hellenic Association of Political Scientists (2016) (2016) [+]
  • 可持续发展目标 (2017) (2017) [+]
  • Joint Coordinating Committee fourth session, Kuwait, 5-7 December 1977: independent chairman's report of proceedings (2019) (2019) [+]
  • 0022416-28 / 05 / 2018-DGPOB-MDS-A - Allegato Utente 1 (A01) (2019) (2019) [+]
  • Addressing the persistent inequities in immunization coverage (2020) (2020) [+]